Immune response treated with bone marrow mesenchymal stromal cells after stroke

Stroke is a leading cause of death and long-term disability worldwide. Tissue plasminogen activator (tPA) is an effective treatment for ischemic stroke. However, only a small part of patients could benefit from it. Therefore, finding a new treatment is necessary. Bone marrow mesenchymal stromal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zili, Wang, Xudong, Liao, Yidong, Chen, Guangtang, Xu, Kaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530191/
https://www.ncbi.nlm.nih.gov/pubmed/36203971
http://dx.doi.org/10.3389/fneur.2022.991379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530191/
https://www.ncbi.nlm.nih.gov/pubmed/36203971
http://dx.doi.org/10.3389/fneur.2022.991379

Ejemplares similares